Stocks · Health care · Pharmaceutical Preparations

TG THERAPEUTICS, INC.

TGTX Clue Score73

United States Fiscal year ends December CIK 0001001316 Results filed 3 Aug 2026

Add to watchlist

By person

10 insiders · 39 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Sean A Power

CFO

—

$6.93M (14)

−$6.93M

798,111

0.5214%

$43.86M

+127.1%

Ra Capital Management, L.p. entity

10% owner

—

$4.09M (1)

−$4.09M

12,629,868

8.25%

$694.14M

−1.2%

Sagar Lonial

Director

—

$2.15M (6)

−$2.15M

94,061

0.0615%

$5.17M

+135.2%

Yann Echelard

Director

$95.76K (1)

$2.22M (4)

−$2.13M

223,816

0.1462%

$12.30M

+157.1%

Laurence N Charney

Director

—

$2.13M (6)

−$2.13M

168,640

0.1102%

$9.27M

+75.8%

William James Kennedy

Director

—

$566.49K (3)

−$566.49K

109,633

0.0716%

$6.03M

+0.6%

Michael S Weiss

CEO

$1.36M (2)

$1.28M (2)

+$82.22K

24,212,300

15.82%

$1.33B

+20.5%

Kenneth Hoberman

Director

—

279,653

0.1827%

$15.37M

+221.8%

Daniel Hume

Director

—

192,748

0.1259%

$10.59M

+208.6%

Mark Schoenebaum

Director

—

125,949

0.0823%

$6.92M

+31.3%

TG THERAPEUTICS, INC.

What the insiders did Net selling

By person